ProductLife Group at the European Pharmacovigilance Congress 2025

 
The European Pharmacovigilance Congress 2025, organised by Pharma Education Center, is recognised as one of the key international forums for drug safety and pharmacovigilance operations, bringing together authorities, QPPVs, industry leaders and experts to discuss scientific, regulatory and organisational priorities for the years ahead.  
Within this context, ProductLife Group does not simply attend as a participant. The Group contributes as a content leader, helping to shape the conversation on how safety systems evolve in a world where new data sources, AI and global frameworks are redefining expectations. 

Among PLG’s contributions, particular attention goes to the intervention of Gabrièle Piaton-Breda, Research & Innovation Director at PLG, who focuses on Human AI collaboration in pharmacovigilance. Her session explores how human oversight and intelligent technologies can interact in a structured way, so that AI supports, rather than replaces, expert judgement. 
Key themes include the role of AI in signal detection, the impact on risk assessment and decision support, and the importance of clear governance models that define responsibilities, validation, monitoring and escalation. The aim is to move beyond generic discussions on automation and address what it truly means to build PV systems that are AI-enabled, transparent and inspection-ready. 

The topics at the European Pharmacovigilance Congress reflect issues that PLG teams encounter daily: the integration of real-world data into safety evaluation, the alignment of global PV frameworks, the management of audits and inspections, and the introduction of digital tools without compromising control.  
Through its global network, ProductLife Group supports organisations in translating these priorities into practical solutions. This includes the design and optimisation of PV systems and QMS, support for GVP compliance and inspection readiness, optimisation of signal management processes, and strategic guidance on AI and data governance within safety operations. The focus is always on building structures that are robust, scalable and proportionate to each company’s portfolio, markets and risk profile.

For companies that want to strengthen or transform their pharmacovigilance set-up, PLG offers a combination of scientific expertise, regulatory insight and operational experience across regions. The Group provides support along the entire PV lifecycle, from early system design and global process harmonisation to vendor oversight, technology enablement and post-inspection remediation. 
Participation in events such as the European Pharmacovigilance Congress 2025 reinforces this role. By contributing to the scientific dialogue and sharing concrete experience from real projects, ProductLife Group helps organisations move towards safety models that protect patients, satisfy regulators and support long-term business strategy. 

If you are interested or would like to explore further, contact us